Norish says its cold store division has increased its profit contribution by 38% to £1.09m in the first four months of the financial year.
The sourcing businesses made a reduced profit of £141,000, down from £184,000. The dairy division is set to perform better this year.
In the first four months of 2019, group pre-tax profit improved 80% to £754,000. Net debt is reducing from he £4.9m figure at the end of 2018.
Even if the rate of profit growth does not continue, earnings per share should be higher than the 5p reported last year. The current share price is 66p.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.